PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.19%
Revenue growth above 1.5x 3391.T's 2.74%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2.25%
Gross profit growth similar to 3391.T's 2.35%. Walter Schloss would assume both firms track common industry trends.
4.51%
EBIT growth below 50% of 3391.T's 27.64%. Michael Burry would suspect deeper competitive or cost structure issues.
4.40%
Operating income growth under 50% of 3391.T's 27.71%. Michael Burry would be concerned about deeper cost or sales issues.
-2.80%
Negative net income growth while 3391.T stands at 19.02%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.81%
Negative EPS growth while 3391.T is at 19.60%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.81%
Negative diluted EPS growth while 3391.T is at 19.60%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.34%
10Y revenue/share CAGR above 1.5x 3391.T's 27.32%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
55.34%
5Y revenue/share CAGR above 1.5x 3391.T's 27.32%. David Dodd would look for consistent product or market expansions fueling outperformance.
55.34%
3Y revenue/share CAGR above 1.5x 3391.T's 27.32%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.68%
Net income/share CAGR above 1.5x 3391.T's 63.36% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.68%
5Y net income/share CAGR above 1.5x 3391.T's 63.36%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
152.68%
3Y net income/share CAGR above 1.5x 3391.T's 63.36%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
82.37%
10Y equity/share CAGR above 1.5x 3391.T's 29.30%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
82.37%
5Y equity/share CAGR above 1.5x 3391.T's 29.30%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
82.37%
3Y equity/share CAGR above 1.5x 3391.T's 29.30%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.19%
Inventory is declining while 3391.T stands at 2.49%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.57%
Negative asset growth while 3391.T invests at 0.75%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.07%
1.25-1.5x 3391.T's 3.01%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-13.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.